 Subjects for this study will be recruited from Dr. Devis clinical practice. Eligible subjects must have a diagnosis of possible or probable Alzheimers disease using NINCDS-ADRDA criteria. The patient and his or her legally authorized representative need to be available to sign the informed consent. The assent of the incapable subject will be obtained prior to enrolling the subject in the study. 